Jung O - Search Results

1

Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.

Jung O, Brandes RP, Kim IH, Schweda F, Schmidt R, Hammock BD, Busse R, Fleming I. Jung O, et al. Hypertension. 2005 Apr;45(4):759-65. doi: 10.1161/01.HYP.0000153792.29478.1d. Epub 2005 Feb 7. Hypertension. 2005. PMID: 15699457

2

Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease.

Jung O, Jansen F, Mieth A, Barbosa-Sicard E, Pliquett RU, Babelova A, Morisseau C, Hwang SH, Tsai C, Hammock BD, Schaefer L, Geisslinger G, Amann K, Brandes RP. Jung O, et al. PLoS One. 2010 Aug 4;5(8):e11979. doi: 10.1371/journal.pone.0011979. PLoS One. 2010. PMID: 20694143 Free PMC article.

3

Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice.

Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, Brandes RP. Jung O, et al. Circ Res. 2003 Oct 3;93(7):622-9. doi: 10.1161/01.RES.0000092140.81594.A8. Epub 2003 Aug 21. Circ Res. 2003. PMID: 12933702

4

Inactivation of extracellular superoxide dismutase contributes to the development of high-volume hypertension.

Jung O, Marklund SL, Xia N, Busse R, Brandes RP. Jung O, et al. Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):470-7. doi: 10.1161/01.ATV.0000254823.15843.1f. Epub 2006 Dec 14. Arterioscler Thromb Vasc Biol. 2007. PMID: 17170376

5

Sympathoactivation and rho-kinase-dependent baroreflex function in experimental renovascular hypertension with reduced kidney mass.

Pliquett RU, Benkhoff S, Jung O, Brandes RP. Pliquett RU, et al. Among authors: jung o. BMC Physiol. 2014 Jun 19;14:4. doi: 10.1186/1472-6793-14-4. BMC Physiol. 2014. PMID: 24946879 Free PMC article.

6

gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension.

Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, Brandes RP. Jung O, et al. Circulation. 2004 Apr 13;109(14):1795-801. doi: 10.1161/01.CIR.0000124223.00113.A4. Epub 2004 Mar 22. Circulation. 2004. PMID: 15037533

7

Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet.

Schröder K, Vecchione C, Jung O, Schreiber JG, Shiri-Sverdlov R, van Gorp PJ, Busse R, Brandes RP. Schröder K, et al. Among authors: jung o. Free Radic Biol Med. 2006 Nov 1;41(9):1353-60. doi: 10.1016/j.freeradbiomed.2006.03.026. Epub 2006 Apr 4. Free Radic Biol Med. 2006. PMID: 17023262

8

Role of Nox4 in murine models of kidney disease.

Babelova A, Avaniadi D, Jung O, Fork C, Beckmann J, Kosowski J, Weissmann N, Anilkumar N, Shah AM, Schaefer L, Schröder K, Brandes RP. Babelova A, et al. Among authors: jung o. Free Radic Biol Med. 2012 Aug 15;53(4):842-53. doi: 10.1016/j.freeradbiomed.2012.06.027. Epub 2012 Jun 27. Free Radic Biol Med. 2012. PMID: 22749956

9

Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease.

Babelova A, Jansen F, Sander K, Löhn M, Schäfer L, Fork C, Ruetten H, Plettenburg O, Stark H, Daniel C, Amann K, Pavenstädt H, Jung O, Brandes RP. Babelova A, et al. Among authors: jung o. PLoS One. 2013 Nov 7;8(11):e80328. doi: 10.1371/journal.pone.0080328. eCollection 2013. PLoS One. 2013. PMID: 24244677 Free PMC article.

10

Resistant hypertension? Assessment of adherence by toxicological urine analysis.

Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, Toennes SW. Jung O, et al. J Hypertens. 2013 Apr;31(4):766-74. doi: 10.1097/HJH.0b013e32835e2286. J Hypertens. 2013. PMID: 23337469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page